Jeffrey Drebin researcher
Drebin, Jeffrey A.
VIAF ID: 36145541822696601288 (Personal)
Permalink: http://viaf.org/viaf/36145541822696601288
Preferred Forms
- 100 1 _ ‡a Drebin, Jeffrey A.
- 100 1 _ ‡a Drebin, Jeffrey A.
- 100 0 _ ‡a Jeffrey Drebin ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial | |
Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program. | |
The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy | |
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients | |
CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma | |
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal | |
Defining postoperative weight change after pancreatectomy: Factors associated with distinct and dynamic weight trajectories | |
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia | |
Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy | |
Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions | |
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer | |
Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes | |
Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors | |
Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy | |
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies | |
Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? | |
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial | |
The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN). | |
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma | |
ErbB receptors: from oncogenes to targeted cancer therapies | |
Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index. | |
Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution | |
Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios. | |
Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy | |
Hepatocellular carcinoma in patients with no identifiable risk factors | |
Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein | |
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis. | |
Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients | |
Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base | |
Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma. | |
Incidence of venous thromboembolism in patients undergoing surgical treatment for malignancy by type of neoplasm: An analysis of ACS-NSQIP data from 2005 to 2010. | |
Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen | |
Intraoperative Molecular Imaging: The Surgical Oncologist's North Star | |
Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection | |
Invasive central venous monitoring during hepatic resection: unnecessary for most patients | |
Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients | |
Lending a hand for laparoscopic distal pancreatectomy: the optimal approach? | |
Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study. | |
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells | |
Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes | |
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene | |
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification | |
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms | |
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival. | |
Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model | |
The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas. | |
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies. | |
Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study | |
A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection | |
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer | |
A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma | |
Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery | |
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma | |
Prophylactic octreotide for pancreatoduodenectomy: more harm than good? | |
Prospective trial of a blood supply-based technique of pancreaticojejunostomy: effect on anastomotic failure in the Whipple procedure | |
Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective. | |
Radical antegrade modular pancreatosplenectomy | |
Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy | |
Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations | |
Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation | |
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group | |
Risk factors for aggressive nonfunctional pancreatic neuroendocrine tumors and the role of endoscopic ultrasound guided fine-needle aspiration | |
The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies | |
Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies | |
Successful venous repair and reconstruction for oncologic resections | |
Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer | |
Surgical palliation for pancreatic malignancy: practice patterns and predictors of morbidity and mortality | |
The surgical review, 2016: | |
Targeted suppression of beta-catenin blocks intestinal adenoma formation in APC Min mice | |
Timing of preoperative pharmacoprophylaxis for pancreatic surgery patients: a venous thromboembolism reduction initiative | |
Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer | |
Use of a bipolar vessel-sealing device for parenchymal transection during liver surgery | |
Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies | |
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy |